收藏切换
Panax notoginseng saponins mediated inhibition of human aortic valve interstitial cell calcification via SYK/NF-κB pathway
收藏切换
PDF
Hong-zheng LI1, 2, Guo-sheng LIN3, Bin ZHANG4, Zhen MENG5, Zi-ang LI4, Qiu-yi LI1, Xiao-shan CUI1, Zi-kai YU1, *
Chinese Journal of Traditional Chinese Medicine | 2026, 51(1) : 241 - 249
Less
收藏切换
Chinese Journal of Traditional Chinese Medicine | 2026, 51(1): 241-249
Panax notoginseng saponins mediated inhibition of human aortic valve interstitial cell calcification via SYK/NF-κB pathway
Full
Hong-zheng LI1, 2, Guo-sheng LIN3, Bin ZHANG4, Zhen MENG5, Zi-ang LI4, Qiu-yi LI1, Xiao-shan CUI1, Zi-kai YU1, *
Affiliations
  • 1.National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
  • 2.Postdoctoral Research Station, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
  • 3.Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
  • 4.Coronary Heart Disease Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
  • 5.Department of Cardiology, China-Japan Friendship Hospital, Beijing 100029, China
Published: 2026-01-01 doi: 10.19540/j.cnki.cjcmm.20250926.802
Outline
收藏切换

Using bioinformatics analysis, network pharmacology, and cellular experiments, this study investigated the effects and potential mechanisms of Panax notoginseng saponins (PNS) on osteogenic induction of immortalized human aortic valve interstitial cells (hVICs). A calcific aortic valve disease (CAVD) cell model was established by treating hVICs with osteogenic induction medium (OM). Experimental groups included a control group, a model group, and PNS treatment groups (0.075, 0.05, and 0.025 mg·mL-1). Cell viability was assessed by the CCK-8 assay. Calcification was evaluated by alkaline phosphatase (ALP) and alizarin red S staining. Western blot was performed to measure the expression of calcification-related proteins runt-related transcription factor 2 (RUNX2), bone morphogenetic protein 2 (BMP2), and ALP. Transcriptomic datasets related to CAVD were obtained from the Gene Expression Omnibus (GEO) database, and CAVD disease targets were retrieved from GeneCards. Active components of PNS and their potential targets were collected from HERB, Batman-TCM 2.0, and ETCM databases. The intersecting genes were subjected to protein-protein interaction (PPI) network construction, Gene Ontology (GO) enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, identifying the spleen tyrosine kinase (SYK)/nuclear factor kappa-B (NF-κB) signaling pathway as a core pathway. Western blot was then used to assess the effects of PNS at the optimal concentration on SYK/NF-κB pathway-related proteins. NF-κB p65 nuclear translocation was examined by immunofluorescence co-localization, and ELISA was applied to measure tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) levels. Results showed that PNS reduced alizarin red S and ALP staining in calcification-induced hVICs and downregulated calcification-related proteins BMP2, ALP, and RUNX2 (P<0.05, P<0.01), with the most significant effect observed at 0.075 mg·mL-1. A total of 1 416 differentially expressed genes were identified from GEO, while 5 646 CAVD-related targets were obtained from GeneCards. From HERB, Batman-TCM 2.0, and ETCM, 605 PNS targets were collected, with 130 overlapping genes identified. These were mainly involved in inflammatory responses, lipopolysaccharide-mediated signaling, transcriptional regulation, protein phosphorylation, and NF-κB pathway activation, occurring primarily in membrane rafts and the golgi apparatus, with molecular functions such as kinase activity regulation and protein binding, and enriched in lipid metabolism, atherosclerosis, and NF-κB signaling pathways. Experimental validation showed that PNS significantly decreased NF-κB p65 expression (P<0.05), significantly increased IκBα expression (P<0.01), and markedly suppressed expression of p-SYK (P<0.01), p-IκBα (P<0.01), p-NF-κB p65 (P<0.01), and p-NF-κB p50 (P<0.01). PNS also significantly reduced NF-κB p65 nuclear/cytoplasmic fluorescence intensity (P<0.01), decreased TNF-α secretion in the supernatant (P<0.01), and promoted IL-10 secretion (P<0.01). In conclusion, PNS ameliorates hVICs calcification by downregulating IκBα, NF-κB p65, and NF-κB p50 expression, inhibiting phosphorylation of SYK, IκBα, NF-κB p65, and NF-κB p50, reducing NF-κB p65 nuclear translocation, and suppressing TNF-α expression.

Panax notoginseng saponins  /  calcific aortic valve disease  /  aortic valve interstitial cells  /  SYK/NF-κB signaling pathway
Hong-zheng LI, Guo-sheng LIN, Bin ZHANG, Zhen MENG, Zi-ang LI, Qiu-yi LI, Xiao-shan CUI, Zi-kai YU. Panax notoginseng saponins mediated inhibition of human aortic valve interstitial cell calcification via SYK/NF-κB pathway[J]. Chinese Journal of Traditional Chinese Medicine, 2026 , 51 (1) : 241 -249 . DOI: 10.19540/j.cnki.cjcmm.20250926.802
Year 2026 volume 51 Issue 1
PDF
54
5
Cite this Article
BibTeX
Article Info
doi: 10.19540/j.cnki.cjcmm.20250926.802
  • Receive Date:2025-09-03
  • Online Date:2026-06-25
  • Published:2026-01-01
Article Data
Affiliations
History
  • Received:2025-09-03
Funding
Affiliations
    1.National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
    2.Postdoctoral Research Station, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    3.Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
    4.Coronary Heart Disease Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
    5.Department of Cardiology, China-Japan Friendship Hospital, Beijing 100029, China
References
Share
https://castjournals.cast.org.cn/joweb/zgzyzz/EN/10.19540/j.cnki.cjcmm.20250926.802
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT